Therapeutic effects of progestins, androgens, and tibolone for menopausal symptoms James H. Liu, MD The American Journal of Medicine Volume 118, Issue 12, Pages 88-92 (December 2005) DOI: 10.1016/j.amjmed.2005.09.040 Copyright © 2005 Elsevier Inc. Terms and Conditions
Figure 1 Increase in sexual activity in surgically menopausal women from baseline after 24 weeks of treatment with either a placebo patch (open bars) or with a 300-μg transdermal testosterone patch (shaded bars) in 2 multicenter trials. The percentage for change within groups is provided in the bars. (Adapted from Kingsberg et al, presentation at the European Society for Sexual Medicine.24) The American Journal of Medicine 2005 118, 88-92DOI: (10.1016/j.amjmed.2005.09.040) Copyright © 2005 Elsevier Inc. Terms and Conditions
Figure 2 Increase in sexual desire in surgically menopausal women from baseline after 24 weeks of treatment with either placebo patch (open bars) or with a 300-μg transdermal testosterone patch (shaded bars) in 2 multicenter trials. The percentage for change within groups is provided in the bars. (Adapted from Kingsberg et al, presentation at the European Society for Sexual Medicine.24) The American Journal of Medicine 2005 118, 88-92DOI: (10.1016/j.amjmed.2005.09.040) Copyright © 2005 Elsevier Inc. Terms and Conditions